WINNIPEG FREE PRESS: A Winnipeg medical diagnostic company has developed a new kit that could make it easier to diagnose patients with prostate cancer. READ MORE>
The new prostate-cancer kit, which took several years to develop, measures the amount of a particular amino acid protein – called PSP94 – in a urine sample from a patient.
PSP94 is found in the cells of the prostate, and there’s a growing body of medical evidence to suggest men with prostate cancer have reduced levels of it in their urine.
But the company, Miraculins, said further research is also needed to confirm the validity of PSP94 as a biomarker for prostate cancer.